TMS in Primary Care: The Future of Mental Health Access

October 3, 2025

Over 70% of antidepressants are prescribed by family doctors, not psychiatrists. So why isn't TMS in every primary care office?In this paradigm-shifting episode of The Kind Revolution Podcast, host Nate and Dr. Georgine Nanos explore why Transcranial Magnetic Stimulation (TMS) belongs in primary care settings - where most mental health journeys actually begin. Dr. Nanos reveals the uncomfortable truth about antidepressant effectiveness from the landmark STAR*D study: only 1 in 3 patients respond to their first medication, leaving two-thirds cycling through trial-and-error while managing debilitating side effects.

The conversation explores how primary care physicians are the true front line of mental health, yet have been fighting brain health problems with limited tools for decades. 


Dr. Nanos shares compelling patient stories - from the postpartum mom afraid to take medications while breastfeeding to the burned-out executive who needed his brain back - demonstrating how TMS in primary care settings removes stigma, reduces wait times, and provides targeted circuit-based treatment without systemic side effects.

Meet the Author

About Dr. Nanos

You might also enjoy:


Red LED screen displaying rows of illuminated dots, perspective view.
February 20, 2026
Is red light therapy worth it? Learn what the science actually shows about light therapy, where it works, and where wellness marketing overpromises.
Promotional graphic: two women smiling, text:
February 20, 2026
In this episode of the Kind Revolution Podcast lease why better time management doesnt fix exhaustion and how brain-body healing through TMS therapy and comprehensive medical care finally helped her reclaim her life as a mom and business owner.
February 16, 2026
When you treat the whole system instead of isolated symptoms, you get transformations that ripple through every part of life.
White letters on black background:
February 9, 2026
Dr. Georgine Nanos explains why Galleri multi-cancer screening is crucial for detecting pancreatic, ovarian, and other deadly cancers before symptoms appear.